gnrh agonist trigger versus hcg trigger in gnrh antagonist in ivf/icsi cycles: a review article
Clicks: 251
ID: 214234
2016
Article Quality & Performance Metrics
Overall Quality
Not rated
Combines reader engagement with the AI quality analysis. This
article has not been analysed, so there is no overall score —
reader engagement is measured and shown alongside.
Reader Engagement
Steady Performance
30.0
/100
251 views
46 readers
AI Quality Assessment
Not analyzed
Readership in this journal
SteadyRanked #27 of 51 articles by views in isprs international journal of geo-information
Most read
Least read
Bar heights use a square-root scale.
Mint this article as an NFT
Not yet mintedCreate a permanent, verifiable on-chain record of this article on the Scimatic Network. The NFT is held in your Journament account, and you can withdraw it to your own wallet at any time.
5
SUSD
one-off · no wallet required
Abstract
Routinely, a bolus of 5.000-10.000 IU human chorionic gonadotropin (hCG) is used
for the final follicular maturation and ovulation as a standard method. HCG has the
same effect of luteinizing hormone (LH) with long half-life. It has the long
lutheotrophic effect which increases the risk of ovarian hyper stimulation syndrome
(OHSS). Recently, gonadotropin-releasing hormone agonist (GnRH-a) trigger has
been used for the induction of final follicular maturation and ovulation with the aim
of reducing the OHSS risk. Several studies have shown that the releases of
endogenous follicular stimulating hormone (FSH) and LH after administration of
GnRH agonist in in vitro fertilization (IVF) cycles are able to precede the final
follicular maturation leading to removal of fertile oocyte with normal development
of the embryo and ultimately pregnancy. But based on the results of some studies,
using GnRH-a trigger leads to defect luteal-phase resulting to reduce the
implantation and clinical pregnancy rates and also increase abortion in fresh embryo
transfer cycles compared to routine IVF cycle with hCG triggering . Also, in recent
years, studies have continued to modify the luteal phase support, so that the fresh
embryo transfer is possible too. In this review, we examined the benefits, problems,
and also ways to reform GnRH agonist triggering complications.
| Reference Key |
alyasin2016iraniangnrh
Use this key to autocite in the manuscript while using
SciMatic Manuscript Manager or Thesis Manager
|
|---|---|
| Authors | ;Ashraf Alyasin;Shayesteh Mehdinejadiani;Candidate. Marzieh Ghasemi |
| Journal | isprs international journal of geo-information |
| Year | 2016 |
| DOI |
DOI not found
|
| URL | |
| Keywords |
Citations
No citations found. To add a citation, contact the admin at info@scimatic.org
Comments
No comments yet. Be the first to comment on this article.